The Rockefeller University Clinical Scholars Program
The KL2 Clinical Scholars Master’s Program is a training experience designed to prepare physician-scientists and select doctoral level PhD investigators for independent careers in clinical and patient-oriented translational research. The program leads to a Master's degree in Clinical and Translational Research. The program is funded in part by a KL2 grant from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), which is linked to the University's Clinical and Translational Science Award (CTSA). In addition, some Clinical Scholars are funded from Rockefeller University endowment funds. Those individuals who demonstrate superior performance during the program are eligible to extend their training in the Rockefeller University Graduate School as candidates for the PhD degree. The program is designed to provide an optimal environment and mentoring structure for the Clinical Scholar to develop the experience and capabilities necessary to initiate an independent career as a patient-oriented and translational investigator.
The Rockefeller University
The Rockefeller University was founded in 1901 by John D. Rockefeller as The Rockefeller Institute for Medical Research, the nation’s first biomedical research institute. In 1910, Rockefeller opened the first hospital in the United States devoted to exclusively to applying scientific methods to study the nature, cause, and treatment of human disease.
The University is devoted exclusively to biomedical research and organized around ~80 laboratories headed by some of the world’s most outstanding scientists. At present, the scientific staff at Rockefeller includes 25 Nobel Laureates, 23 recipients of Albert Lasker awards, 38 members of the National Academy of Sciences, 3 recipients of MacArthur Foundation “genius” awards, 20 recipients of the National Medical of Science, and 3 recipients of the Breakthrough Prize of Life Sciences. Rockefeller investigators are studying many clinical conditions and related problems, including heart disease and stroke, cancer, diabetes, Alzheimer disease, obesity and nutrition, hepatitis, autism, HIV/AIDS, aging, skin diseases, and disorders of consciousness, smell, and face recognition.
The Rockefeller University Hospital
The Rockefeller University Hospital is the only private hospital in the U.S. devoted exclusively to clinical research. On October 26, 1910, the new Rockefeller Institute Hospital admitted its first research participant, opening up a new era of biomedical investigation in which physicians were given the resources and encouragement to engage in fundamental studies in the hospital laboratories of the disease problems they dealt with on the hospital wards. Today, the Hospital continues this more than 100-year tradition of a two-way interchange between laboratory and clinic, with benefits for both our understanding of biologic processes and the treatment and prevention of disease.
The Rockefeller University Center for Clinical and Translational Science is devoted to maximizing the bidirectional opportunities for clinical and translational research. Building on Rockefeller University Hospital's history as the birthplace of American translational research, and supported in part, by a Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, the Center is designed to provide an optimal infrastructure to conduct clinical and translational research and to educate the next generation of physician scientists committed to patient-oriented research. The Center for Clinical and Translational Science continues Rockefeller University's tradition of focusing on the interface between scientific discovery, human pathophysiology, and novel diagnostic, preventative and therapeutic strategies to benefit all of humanity. |
